liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Östergötlands Läns Landsting, Centre of Surgery and Oncology, Department of Surgery in Östergötland. (Landstinget i Östergötland)
Linköping University, Faculty of Health Sciences. Linköping University, Department of Clinical and Experimental Medicine, Oncology .
Linköping University, Faculty of Health Sciences. Linköping University, Department of Clinical and Experimental Medicine, Oncology .
Karolinska University Hospital.
Show others and affiliations
2009 (English)In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ISSN 0360-3016, Vol. 75, no 1, 137-142 p.Article in journal (Refereed) Published
Abstract [en]

Purpose: FXYD-3 (MAT-8) is overexpressed in several types of cancers; however, its clinical relevance in rectal cancers has not been studied. Therefore, we examined FXYD-3 expression in rectal cancers from the patients who participated in a Swedish clinical trial of preoperative radiotherapy (RT) to determine whether FXYD-3 was overexpressed in rectal cancers and correlated with RT, survival, and other clinicopathologic variables. Methods and Materials: The study included 140 rectal cancer patients who participated in a clinical trial of preoperative RT, 65 with and 75 without RT before surgery. FXYD-3 expression was immumohistochemically examined in distant (n = 70) and adjacent (n = 101) normal mucosa, primary tumors (n = 140), and lymph node metastasis (n = 36). Results: In the whole cohort, strong FXYD-3 expression was correlated with infiltrative tumor growth (p = 0.02). In the RT group, strong FXYD-3 expression alone (p = 0.02) or combined with phosphatase of regenerating liver was associated with an unfavorable prognosis (p = 0.02), independent of both TNM stage and tumor differentiation. In tumors with strong FXYD-3 expression, there was less tumor necrosis (p = 0.02) and a trend toward increased incidence of distant metastasis (p = 0.08) after RT. None of these effects was seen in the non-RT group. FXYD-3 expression in the primary tumors tended to he increased compared with normal mucosa regardless of RT. Conclusion: FXYD-3 expression was a prognostic factor independent of tumor stage and differentiation in patients receiving preoperative RT for rectal cancer.

Place, publisher, year, edition, pages
2009. Vol. 75, no 1, 137-142 p.
Keyword [en]
FXYD-3, Rectal cancer, Radiotherapy, Prognosis, Immunohistochemistry
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-20598DOI: 10.1016/j.ijrobp.2008.10.076OAI: diva2:235517
Available from: 2009-09-16 Created: 2009-09-15 Last updated: 2009-09-16

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Önnesjö, SofiaWidegren, EmmaSun, Xiao-Feng
By organisation
Department of Surgery in ÖstergötlandFaculty of Health SciencesOncology Department of Oncology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 43 hits
ReferencesLink to record
Permanent link

Direct link